Evidence map›Paper›PMID 42539433›Full record

ArticleFrontiers in medicine2026

Ga-68 FAPI-04 PET/CT detection of repeatedly biopsy-negative poorly differentiated gastric adenocarcinoma: a case report.

Zhipeng Cheng, Xiuxiu Chang, Yuying Lei, Na Liu, Jing Wu, Lifei Zhang, Aixia Sui

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhipeng ChengGraduate School, Hebei North University, Zhangjiakou, Hebei, China.
Xiuxiu ChangGraduate School, Hebei North University, Zhangjiakou, Hebei, China.
Yuying LeiDepartment of Oncology, Hebei General Hospital, Shijiazhuang, Hebei, China.
Na LiuDepartment of Gastroenterology, Hebei General Hospital, Shijiazhuang, Hebei, China.
Jing WuDepartment of Gastroenterology, Hebei General Hospital, Shijiazhuang, Hebei, China.
Lifei ZhangDepartment of Gastrointestinal Surgery, Hebei General Hospital, Shijiazhuang, Hebei, China.
Aixia SuiDepartment of Oncology, Hebei General Hospital, Shijiazhuang, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

False-negative endoscopic biopsy may delay the diagnosis of infiltrative gastric cancer, particularly in poorly differentiated or signet-ring cell phenotypes. We report a 56-year-old man with progressive abdominal distension, nausea, vomiting, weight loss, and epigastric pain. Three endoscopic biopsies performed before and after transfer to our hospital showed chronic inflammation without definite malignancy. F-18 FDG PET/CT demonstrated slightly increased and indistinct uptake compared with the liver in the thickened gastric antrum wall, whereas subsequent Ga-68 FAPI-04 PET/CT showed intense uptake with clearer lesion delineation. Because of progressive gastric outlet obstruction and persistent clinical suspicion, distal gastrectomy was performed for symptom relief and definitive diagnosis. Final histopathology confirmed poorly differentiated gastric adenocarcinoma with partial signet-ring cell morphology. The patient subsequently received postoperative XELOX chemotherapy and remained clinically stable at the 7-months follow-up. This case suggests that Ga-68 FAPI-04 PET/CT may serve as a problem-solving adjunct when repeated endoscopic biopsies are non-diagnostic but suspicion for infiltrative gastric cancer persists.

Indexed as

F-18 FDGfalse-negative biopsyGa-68 FAPI-04gastric adenocarcinomaPET/CTsignet-ring cell carcinoma

Identifiers

PMID42539433
PMCPMC13423698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.